[1]乐世俊 白雪 黄昱曦 王文晓 高欢 唐于平.羟基红花黄色素A治疗心脑血管疾病作用机制的网络药理学研究[J].陕西中医药大学学报,2021,44(05):106-112.[doi:10.13424/j.cnki.jsctcm.2021.05.022]
　LE Shijun?BAI Xue?HUANG Yuxi?WANG Wenxiao?GAO Huan?TANG Yuping.Mechanism Research of Hydroxysafflower Yellow A in The Treatment of Cardiovascular and Cerebrovascular Diseases by Network pharmacology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(05):106-112.[doi:10.13424/j.cnki.jsctcm.2021.05.022]
点击复制

羟基红花黄色素A治疗心脑血管疾病作用机制的网络药理学研究
分享到：

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
44
期数:
2021年05期
页码:
106-112
栏目:
出版日期:
2021-09-30

文章信息/Info

Title:
Mechanism Research of Hydroxysafflower Yellow A in The Treatment of Cardiovascular and Cerebrovascular Diseases by Network pharmacology
文章编号:
2096-1340(2021)05-0106-07
作者:
乐世俊 白雪 黄昱曦 王文晓 高欢 唐于平
陕西中医药大学，陕西 咸阳 712046
Author(s):
LE Shijun?BAI Xue?HUANG Yuxi?WANG Wenxiao?GAO Huan?TANG Yuping
Shaanxi University of Traditional Chinese Medicine,Shaanxi Xianyang 712046,China
关键词:
羟基红花黄色素A; 网络药理学; 心脑血管疾病; 作用机制
Keywords:
Hydroxysafflower yellow A;  Network pharmacology;  Cardiovascular and cerebrovascular diseases;  Action mechanism
分类号:
R285
DOI:
10.13424/j.cnki.jsctcm.2021.05.022
文献标志码:
A
摘要:
目的 利用网络药理学研究羟基红花黄色素A（HSYA）治疗心脑血管疾病的潜在机制。方法 通过挖掘近10年HSYA治疗心脑血管疾病的相关文献，搜集其抗心脑血管疾病的作用靶点，再利用生物学信息注释数据库（DAVID）进行GO富集及KEGG通路分析，最后采用Cytoscape 3.8.0软件构建“靶点信号通路”交互网络和拓扑分析。结果 HSYA通过调控NFKB1和RELA等94个潜在靶点，干预流体切应力与动脉粥样硬化、TNF信号通路、脂肪细胞因子信号通路和Apelin信号通路等重要信号通路发挥治疗心脑血管疾病的作用。结论 该研究从网络药理学角度初步揭示了HSYA改善心脑血管疾病的多维调控网络机制，为其临床应用提供了理论依据。
Abstract:
Objective To study the potential mechanism of hydroxysafflower yellow A (HSYA) in the treatment of cardiovascular and cerebrovascular diseases by network pharmacology.Methods By excavating the relevant literature on the treatment of cardiovascular and cerebrovascular diseases by HSYA in recent 10 years,the anti cardiovascular and cerebrovascular disease targets were collected,and then the biological information annotation database (DAVID) was used for go enrichment and KEGG pathway analysis.Finally,the “target-signal pathway” interactive network and topology analysis were constructed by Cytoscape 3.8.0 software.Results HSYA plays a role in the treatment of cardiovascular and cerebrovascular diseases by regulating 94 potential targets such as NFKB1 and RELA,intervening in important signal pathways such as fluid shear stress and atherosclerosis,TNF signal pathway,adipocytokine signal pathway and Apelin signal pathway.Conclusion This study preliminarily reveals the multidimensional regulatory network mechanism of HSYA in improving cardiovascular and cerebrovascular diseases from the perspective of network pharmacology,which provides a theoretical basis for its clinical application.

参考文献/References:

［1］胡盛寿,高润霖,刘力生,等.《中国心血管病报告2018》概要［J］.中国循环杂志,2019,34(3)：209-220.
［2］Hao P,Jiang F,Chen Y,et al.Traditional Chinese medication for cardiovascular disease［J］.Nature Reviews Cardiology,2015,12(2)：115-122.
［3］唐梅森,龚后武,黄征德,等.冠心病血瘀证症状与药物组成最大频繁关联模式挖掘［J］.中国中西医结合杂志,2017,37(4)：492-494.
［4］Yue S,Tang Y,Li S,et al.Chemical and biological properties of quinochalcone Cglycosides from the florets of Carthamus tinctorius［J］.Molecules,2013,18 (12)：15220-15254.
［5］Lu Q,Xu J,Li Q,et al.Therapeutic efficacy and safety of safflower injection in the treatment of acute coronary syndrome［J］.EvidenceBased Complementary and Alternative Medicine,2021,Article ID：6617772.
［6］乐世俊,唐于平,王林艳,等.红花中黄酮类化合物的分离与体外抗氧化研究［J］.中国中药杂志,2014,39(17)：3295-3300.
［7］Meselhy MR,Kadota S,Momose Y,et al.Two new quinochalcone yellow pigments from Carthamus tinctorius and Ca2+ antagonistic activity of tinctormine［J］.Chemical & Pharmaceutical Bulletin,1993,41(10)：1796-1802.
［8］Hu MZ,Zhou ZY,Zhou ZY,et al.Effect and safety of hydroxysafflor yellow A for injection in patients with acute ischemic stroke of blood stasis syndrome：A phase II,multicenter,randomized,doubleblind,multipledose,activecontrolled clinical trial［J］.Chinese Journal of Integrative Medicine,2020,26：420-427.
［9］Tian JA controlled,doubleblind,randomized pilot clinical trial of hydroxysafflor yellow a on cognitive function in patients with vascular dementia［J］.Clinical Pharmacology & Therapeutics,2006,79(2)：44.
［10］李梢.网络药理学评价方法指南［J］.世界中医药,2021,16(4)：527-532.
［11］Yue SJ,Liu J,Feng WW,et al.System pharmacologybased dissection of the synergistic mechanism of Huangqi and Huanglian for diabetes mellitus［J］.Frontiers in Pharmacology,2017,8：694.
［12］李泮霖,苏薇薇.网络药理学在中药研究中的最新应用进展［J］.中草药,2016,47 (16)：2938-2942.
［13］Bai X,Wang WX,Fu RJ,et al.Therapeutic potential of hydroxysafflor yellow A on cardiocerebrovascular diseases［J］.Frontiers in Pharmacology,2020,11：01265.
［14］唐颖弘,戴君.活血化瘀类中成药在心脑血管疾病中的使用情况［J］.中医药管理杂志,2021,29 (2)：47-49.
［15］秦劭晨,梁伟雄,温晓文,等.注射用羟基红花黄色素A治疗急性缺血性中风血瘀证疗效观察［J］.中国实验方剂学杂志,2016,22 (21)：157-161.
［16］Xu H,Liu TL,Wang WJ,et al.Proteomic analysis of hydroxysafflor yellow A against cerebral ischemiareperfusion injury in rats［J］.Rejuvenation Research,2019,22：503-512.
［17］Yan K,Wang X,Pan H,et al.Safflower yellow and its main component HSYA alleviate dietinduced obesity in mice：Possible involvement of the increased antioxidant enzymes in liver and adipose tissue［J］.Frontiers in Pharmacology,2020,11：482.
［18］Lee M,Zhao H,Liu X,et al.Protective effect of hydroxysafflor yellow A on nephropathy by attenuating oxidative stress and inhibiting apoptosis in induced type 2 diabetes in rat［J］.Oxidative Medicine and Cellular Longevity,2020,,Article ID：7805393.
［19］Liu J,Yue SJ,Yang ZR,et al.Oral hydroxysafflor yellow A reduces obesity in mice by modulating the gut microbiota and serum metabolism［J］.Pharmacological Research,2018,134：40-50.
［20］Xi S,Zhang Q,Liu C,et al.Effects of hydroxy safflower yellowA on tumor capillary angiogenesis in transplanted human gastric adenocarcinoma BGC-823 tumors in nude mice［J］.Journal of Traditional Chinese Medicine,2012,32(2)：243-248.

相似文献/References:

[1]严谨 王芙蓉 史海龙.基于网络药理学探讨“葛根 －黄芩”药对治疗糖尿病作用机制分析[J].陕西中医药大学学报,2018,(05):173.[doi:DOI:10．13424/j．cnki．jsctcm．2018．05．051]
[2]李正欢 宋雪利 王飞 陈杨梁杨.浅论基于苗医理论的广谱抗肿瘤复方参棱夏[J].陕西中医药大学学报,2020,(5):066.[doi:10.13424/j.cnki.jsctcm.2020.05.017]
　Li Zhenghuan,Song Xueli,Wang Fei,et al.A Discussion on the Broad - spectrum Antitumor Compound Shen Leng Xia Based on Theories of Miao Medicine[J].Journal of Shaanxi University of Traditional Chinese Medicine,2020,(05):066.[doi:10.13424/j.cnki.jsctcm.2020.05.017]
[3]陈奕晨 王娜 王文杰**.淫羊藿抗抑郁作用机制的网络药理学研究[J].陕西中医药大学学报,2021,44(02):053.[doi:10.13424/j.cnki.jsctcm.2021.02.012]
　CHEN Yi - chen,WANG Na,WANG Wen jie.Network Pharmacology Study on Antidepressant Mechanism of Epimedium[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(05):053.[doi:10.13424/j.cnki.jsctcm.2021.02.012]
[4]胡越 许兵兵.网络药理学预测人参抗抑郁作用机制[J].陕西中医药大学学报,2021,44(05):113.[doi:10.13424/j.cnki.jsctcm.2021.05.023]
　HU Yue XU Bingbing.Prediction of Antidepressant Mechanism of Ginseng by Network Pharmacology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(05):113.[doi:10.13424/j.cnki.jsctcm.2021.05.023]
[5]汪宗清 侯卫 聂红科 宋娜 王兴强 汤小虎彭江云.基于网络药理学和分子对接探讨温阳通络方治疗类风湿关节炎的作用机制[J].陕西中医药大学学报,2021,44(05):120.[doi:10.13424/j.cnki.jsctcm.2021.05.024]
　WANG Zongqing HOU Wei NIE Hongke SONG NaWANG Xingqiang TANG XiaohuPENG Jiangyun.Discussion on Wenyang Tongluo Recipe Mechanism of Rheumatoid Arthritis Treatment Based on Network Pharmacology and Molecular Docking[J].Journal of Shaanxi University of Traditional Chinese Medicine,2021,44(05):120.[doi:10.13424/j.cnki.jsctcm.2021.05.024]
[6]于鲲鹏 于永铎.基于网络药理学讨论白花蛇舌草治疗溃疡性结肠炎的作用机制[J].陕西中医药大学学报,2022,(03):087.[doi:10.13424/j.cnki.jsctcm.2022.03.022]
　YU Kunpeng YU Yongduo.Discussion on Mechanism of Hedyotis diffusa in Treatment of Ulcerative Colitis Based on Network Pharmacology[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(05):087.[doi:10.13424/j.cnki.jsctcm.2022.03.022]
[7]程江雪 武旭 郭东艳 史亚军 邹俊波 吴睿彬 张小明.基于网络药理学研究当-归赤芍药对治疗心绞痛作用机制[J].陕西中医药大学学报,2022,(03):097.[doi:10.13424/j.cnki.jsctcm.2022.03.023]
[8]闫浩 刘潇潇 于春雪 孙轲强 成帆 王虎 宋逍.基于网络药理和分子对接探究黄芪葛根汤治疗糖尿病的作用机制[J].陕西中医药大学学报,2022,(04):126.[doi:10.13424/j.cnki.jsctcm.2022.04.028]
　YAN Hao LIU Xiaoxiao YU Chunxue SUN Keqiang CHENG Fan WANG Hu SONG Xiao.Study on Mechanism of Huangqi Gegen Decoction inTreating Diabetes Based on Network Pharmacology and Molecular Docking[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(05):126.[doi:10.13424/j.cnki.jsctcm.2022.04.028]
[9]曹蓓苓 潘赐明 杨晓洁 范瀚中 李奇奇 夏雨欣 陈文慧.基于生物信息技术研究川芎-防风-麻黄角 药治疗缺血性脑卒中的机制[J].陕西中医药大学学报,2022,(06):091.[doi:10.13424/j.cnki.jsctcm.2022.06.018]
[10]王婷 刘维海 张盼 王钰莹 邹俊波 马战平 刘继平 王斌 王川.基于网络药理学和分子对接探讨中研益肺解毒汤防治新型冠状病毒肺炎（COVID-19）的活性成分及靶点[J].陕西中医药大学学报,2023,(02):001.[doi:10.13424/j.cnki.jsctcm.2023.02.001 ]
　WANG Ting LIU Weihai ZHANG Pan WANG Yuying ZOU Junbo MA Zhanping LIU Jiping WANG Bin WANG Chuan.Discussion of Active Components and Targets of Zhongyan Yifei Jiedu Decoction in Prevention and Treatment of COVID-19 Based on Network Pharmacology and Molecular Docking[J].Journal of Shaanxi University of Traditional Chinese Medicine,2023,(05):001.[doi:10.13424/j.cnki.jsctcm.2023.02.001 ]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金青年项目（81903786）；陕西省自然科学基金（2019JQ-054）；陕西中医药大学学科创新团队建设项目（2019-YL10）
更新日期/Last Update: 2021-09-23